Evox Therapeutics Limited Patent Application Trends in 2024
Revision as of 16:15, 19 July 2024 by Wikipatents (talk | contribs) (Updating Evox Therapeutics Limited_Patent_Application_Trends_in_2024)
Contents
Evox Therapeutics Limited Patent Filing Activity
Evox Therapeutics Limited patent applications in 2024
Top 10 Technology Areas
- A61K47/6901 ({Conjugates being cells, cell fragments, viruses, ghosts, red blood cells or viral vectors})
- A61K47/64 (Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent (peptidic linkers)
- A61K47/643 (Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent (peptidic linkers)
- C12N5/0662 (MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media)
- C12P21/02 (having a known sequence of two or more amino acids, e.g. glutathione)
Emerging Technology Areas
- C12P21/02 (having a known sequence of two or more amino acids, e.g. glutathione)
- C12N5/0662 (MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media)
- A61K47/643 (Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent (peptidic linkers)
- A61K47/64 (Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent (peptidic linkers)
- A61K47/6901 ({Conjugates being cells, cell fragments, viruses, ghosts, red blood cells or viral vectors})
Top Inventors
- Christopher DAVIES (1 patent)
- Justin HEAN (1 patent)
- Xiuming LIANG (1 patent)
Patent Categories
Geographical Distribution of Inventors
Geographical Distribution of US Inventors
Evox Therapeutics Limited Inventor States 2024 - Up to June 2024
